venBio Select Advisor »

ImmunoGen shares owned by venBio Select Advisor

Quarter-by-quarter ownership of ImmunoGen shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $26M 875k 29.65
2020-03-31 $6.5M 1.9M 3.41

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen